Candida Infection in Critically Ill Patients

  • P. H. J. van der Voort
Conference paper


Some decades ago, yeasts were not recognized as pathogens [1, 2]. Since the 1980s the pathogenicity of fungi has gained more and more attention, first in immunocompromised patients and later on in critically ill patients as well [3]. Critically ill patients are frequently colonized with yeasts. Amongst other reasons, extensive use of broad spectrum antibiotics in critically ill patients lead to overgrowth in the digestive tract and other organs. Overgrowth is the most important factor in the development of fungal infection. This sequence of events is amplified by decreased motility of the digestive tract during critical illness. In addition, contributing to yeast infection is the fact that critically ill patients are immunodeficient, especially in the cellular immune functions.


Intensive Care Unit Patient Candida Infection Candida Glabrata Candida Colonization Preemptive Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ellis CA, Spivack ML (1967) The significance of candidemia. Ann Intern Med 67:511–513PubMedGoogle Scholar
  2. 2.
    Toala P, Schroeder SA, Daly AK et al (1970) Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. Arch Intern Med 126:983–989PubMedCrossRefGoogle Scholar
  3. 3.
    Solomkin JS, Flohr AB, Quie PG et al (1980) The role of Candida in intraperitoneal infections. Surgery 88:524–530PubMedGoogle Scholar
  4. 4.
    Fraser VJ, Jones M, Dunkel J et al (1992) Candidemia in a tertiary care hospital. Epidemiology, risk factors and predictors of mortality. Clin Infect Dis 15:414–421PubMedGoogle Scholar
  5. 5.
    Charles PE, Dalle F, Aube H et al (2005) Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 31:393–400PubMedCrossRefGoogle Scholar
  6. 6.
    Wallace WC, Cinat ME, Nastanski F et al (2000) New epidemiology for postoperative nosocomial infections. Am Surg 66:874–878PubMedGoogle Scholar
  7. 7.
    Beck-Sague CM, Jarvis WR, and the National Nosocomial Infections Surveillance System (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 167:1247–1251Google Scholar
  8. 8.
    Rogers TH (1998) Nosocomial fungal infections in intensive care unit patients. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the intensive care unit. Springer-Verlag 1998, Milan, pp 144–151Google Scholar
  9. 9.
    De la Cal MA, Cerda E, Garcia-Hierro P et al (2001) Pneumonia in patients with severe burns. A classification according to the concept of the carrier state. Chest 119:1160–1165CrossRefGoogle Scholar
  10. 10.
    Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758PubMedCrossRefGoogle Scholar
  11. 11.
    Voss A, Hollis RJ, Pfaller MA et al (1994) Investigation of the sequence of colonization and candidemia in non-neutropenic patients. J Clin Microbiol 32:975–980PubMedGoogle Scholar
  12. 12.
    Nolla-Salas J, Sitges-Serra A, Leon-Gil C et al (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 23:23–30PubMedCrossRefGoogle Scholar
  13. 13.
    Dimoupoulos G, Karabinis A, Samonis G et al (2007) Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis 26:377–384CrossRefGoogle Scholar
  14. 14.
    Sandven P, Qvist H, Skovlund E et al (2002) Significance of Candida recovered from intraoperative specimen in patients with intra-abdominal perforations. Crit Care Med 30:541–547PubMedCrossRefGoogle Scholar
  15. 15.
    Dupont H, Paugam-Burtz C, Muller-Serieys C et al (2002) Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 137:1341–1346PubMedCrossRefGoogle Scholar
  16. 16.
    Calandra T, Bill J, Schneider R et al (1989) Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 2:1437–1440PubMedCrossRefGoogle Scholar
  17. 17.
    Dupont H, Bourichon A, Paugam-Burtz C et al (2003) Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 31:752–757PubMedCrossRefGoogle Scholar
  18. 18.
    Kobayashi T, Miyazaki Y, Yanagihara K et al (2005) A probable case of aspiration pneumonia caused by Candida glabrata in a non-neutropenic patient with candidemia. Intern Med 44:1191–1194PubMedCrossRefGoogle Scholar
  19. 19.
    Rello J, Esandi ME, Diaz E et al (1998) The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients. Chest 114:146–149PubMedCrossRefGoogle Scholar
  20. 20.
    Azoulay E, Cohen Y, Zahar JR et al (2004) Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 30:1384–1389PubMedGoogle Scholar
  21. 21.
    Magill SS, Swoboda SM, Johnson EA et al (2006) The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis 55:293–301PubMedCrossRefGoogle Scholar
  22. 22.
    Ho KM, Rochford SA, John G (2005) The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: a meta-analysis. Crit Care Med 33:2383–2392PubMedCrossRefGoogle Scholar
  23. 23.
    Silvestri L, van Saene HKF, Milanese M et al (2005) Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials. Intensive Care Med 31:898–910PubMedCrossRefGoogle Scholar
  24. 24.
    Ruijgrok EJ, Vulto AG, van Etten EWM (2001) Efficacy of aerosolised amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats. J Antimicrob Chemoth 48:89–89CrossRefGoogle Scholar
  25. 25.
    Eggimann P, Francioli P, Bille J et al (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066–1072PubMedCrossRefGoogle Scholar
  26. 26.
    Garbino J, Lew DP, Romand JA et al (2002) Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebocontrolled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708–1717PubMedCrossRefGoogle Scholar
  27. 27.
    Pelz RK, Hendrix CW, Swoboda SM et al (2001) Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233:542–548PubMedCrossRefGoogle Scholar
  28. 28.
    Playford EG, Webster AC, Sorrell TC et al (2006) Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 57:628–638PubMedCrossRefGoogle Scholar
  29. 29.
    Shorr AF, Chung K, Jackson WL et al (2005) Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 33:1928–1935PubMedCrossRefGoogle Scholar
  30. 30.
    Piarroux R, Grenouillet F, Balvay P et al (2004) Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32:2443–2449PubMedCrossRefGoogle Scholar
  31. 31.
    Jacobs S, Price Evans DA, Tariq M, Al Omar NF (2003) Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med 31:1938–1946PubMedCrossRefGoogle Scholar
  32. 32.
    Rex JH, Bennett JE, Sugar AM et al (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325–1330PubMedCrossRefGoogle Scholar
  33. 33.
    Anaissie EJ, Darouiche R, Mera J et al (1996) Management of invasive candidal infections: results of a prospective randomized multicenter study of fluconazole versus amphotericin B and review of literature. Clin Infect Dis 23:964–972PubMedGoogle Scholar
  34. 34.
    Kleinberg M (2006) What is the current and future status of conventional amphotericin B? Int J Antimicrob Chemother 27(Suppl 1):12–16CrossRefGoogle Scholar
  35. 35.
    Eriksson U, Seifert B, Schaffner A (2001) Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial. Br Med J 322:579–582CrossRefGoogle Scholar
  36. 36.
    van Braam Houckgeest FA, van der Spoel JE, Oudemans-van Straaten HM et al (2006) No excess renal failure after high dose ampho-B by continuous infusion in ICU patients. Intensive Care Med 32:S56Google Scholar
  37. 37.
    Imhof A, Walter RB, Schaffner A (2003) Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study. Clin Infect Dis 36:943–951PubMedCrossRefGoogle Scholar
  38. 38.
    Abele-Horn M, Kopp A, Sternberg U et al (1996) A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. Infection 24:426–432PubMedCrossRefGoogle Scholar
  39. 39.
    van der Voort PH, Boerma EC, Yska JP (2007) Serum and intraperitoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis. J Antimicrob Chemother 59:952–956PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • P. H. J. van der Voort
    • 1
  1. 1.Department of Intensive CareOnze Lieve Vrouwe GasthuisAmsterdamThe Netherlands

Personalised recommendations